Source: Global Tuberculosis Report 2015
http://www.who.int/tb/publications/global_report/en/
Accessed: 05.10.2019
Asylum and Migration Working Paper 1
Guidance on Implending Publi-Private Mix Approaches
Workshop to share best practices and lessons learned in tuberculosis case finding and treatment in Western and Central Africa, 26 - 28 March 2018
Indonesia's TB Guidelines
World TB Day 24 March 2012
Accessed: 21.10.2019
Despre TBC, profilaxie şi tratament
Vaccinarea: cel mai sigur mod de a-ţi proteja sănătatea
Tuberculosis (TB) is the leading cause of illness and death among people living with HIV. TB can be cured.
Results of an innovative model launched in TB clinics in six regions
Accessed: 12.03.2020
This page contains documents and data related to the UN High-Level Meeting (HLM) on TB key targets and commitments for 2022 and outlined in the Political Declaration of the UN High-Level Meeting on the Fight Against TB.
La tuberculosis o TB, como se le conoce en inglés, es una enfermedad causada por la bacteria Mycobacterium tuberculosis. Estas bacterias por lo general atacan a los pulmones, pero también pueden atacar otras partes del cuerpo, como los riñones, la columna vertebral y el cerebro. Si no se trata ap...ropiadamente, la tuberculosis puede ser mortal
more
Public expenditure on TUBERCULOSIS in EL SALVADOR, during the fiscal year 2018
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the... 3906 notified TB patients were tested for RR-TB and only 12 lab confirmed RR-TB patients were initiated on standard MDR-TB treatment of 20-months duration, (a 3-fold increase in RR-TB detection compared with 2017). This amounts to treatment coverage of only 17% of 72 estimated MDR/RR-TB among notified TB patients (3906) and 5% of 240 estimated incident MDR-TB patients as compared to 62% treatment coverage of 6300 incident drug sensitive TB patients estimated in TLS. The treatment success in the 2016 annual cohort of 6 MDR-TB patients has been reported at 83%. 80% of TB patients know their HIV Status with around 1% TB-HIV co-infection, 37/ 77 (48%) TB-HIV Co-infection Detected. Of the 387 PLHIV currently alive on ART, exact status on TB screening and testing is unknown. % of PLHIV newly enrolled in HIV care who received IPT is not known.
In 2018, the mortality rate for TB was 94 deaths per 100,000 people (1200 per annum) in TL with an increasing mortality trend (Figure 1), despite TB services being available for nearly two decades.
A survey of catastrophic costs due to TB (2016) highlights that 83% of TB patients are reported to be facing catastrophic costs due to the disease. This is the highest rate in the world.
more